Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

AI Digital Pathology Software Firm Proscia Receives CE Mark

Proscia
By Author Proscia | November 7, 2019

Proscia has received a CE Mark for its Concentriq Dx solution for use in primary diagnosis. With this certification, Proscia accelerates its entry into the diagnostic pathology market in Europe and other key geographies globally to help laboratories keep pace with the rising cancer burden. Read more here:

Our website uses cookies. By using this site, you agree to its use of cookies.